Black Diamond Therapeutics, Inc. SEC filings BDTX
Black Diamond Therapeutics, Inc. has 485 filings in SEC EDGAR's recent list, going back to Mar 28, 2017. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 5, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Sep 21, 2026 | Sep 18, 2026 |
| 4 | Insider transaction | Sep 21, 2026 | Sep 18, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 27, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 8, 2026 | — |
| 4 | Insider transaction | Jun 29, 2026 | Jun 26, 2026 |
| 4 | Insider transaction | Jun 29, 2026 | Jun 26, 2026 |
| 4 | Insider transaction | Jun 29, 2026 | Jun 26, 2026 |
| 4 | Insider transaction | Jun 29, 2026 | Jun 26, 2026 |
| 4 | Insider transaction | Jun 29, 2026 | Jun 26, 2026 |
| 4 | Insider transaction | Jun 29, 2026 | Jun 26, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 29, 2026 | Jun 26, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 19, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 19, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 21, 2026 | May 21, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| ARS | Annual report to shareholders | Apr 29, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 29, 2026 | — |
| DEF 14A | Proxy statement | Apr 29, 2026 | Jun 26, 2026 |
| 4 | Insider transaction | Mar 20, 2026 | Mar 20, 2026 |
| 4 | Insider transaction | Mar 20, 2026 | Mar 20, 2026 |
| S-8 | Employee stock plan registration | Mar 16, 2026 | — |
| 10-K | Annual report | Mar 16, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 16, 2026 | Mar 16, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| 4 | Insider transaction | Jan 23, 2026 | Jan 21, 2026 |
| 4 | Insider transaction | Jan 23, 2026 | Jan 21, 2026 |
| 4 | Insider transaction | Jan 23, 2026 | Jan 21, 2026 |
| 4 | Insider transaction | Jan 23, 2026 | Jan 21, 2026 |
| 4 | Insider transaction | Jan 23, 2026 | Jan 21, 2026 |
| 4 | Insider transaction | Dec 15, 2025 | Dec 12, 2025 |
| 4 | Insider transaction | Dec 15, 2025 | Dec 12, 2025 |
| EFFECT | Filing | Dec 3, 2025 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Dec 3, 2025 | Dec 3, 2025 |
| CORRESP | Letter to the SEC | Dec 1, 2025 | — |
| S-3 | Shelf registration | Nov 13, 2025 | — |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 4 | Insider transaction | Sep 22, 2025 | Sep 19, 2025 |
| 4 | Insider transaction | Sep 22, 2025 | Sep 19, 2025 |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 4 | Insider transaction | Jun 20, 2025 | Jun 20, 2025 |
| 4 | Insider transaction | Jun 20, 2025 | Jun 20, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 12, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2025 | Jun 12, 2025 |
| 10-Q | Quarterly report | May 12, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 12, 2025 | May 12, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 29, 2025 | — |
| ARS | Annual report to shareholders | Apr 18, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 18, 2025 | — |
| DEF 14A | Proxy statement | Apr 18, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Mar 21, 2025 | Mar 21, 2025 |
| 4 | Insider transaction | Mar 21, 2025 | Mar 21, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 21, 2025 | — |
| 4 | Insider transaction | Mar 20, 2025 | Mar 19, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Mar 19, 2025 | Mar 18, 2025 |
| S-8 | Employee stock plan registration | Mar 6, 2025 | — |
| 10-K | Annual report | Mar 6, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 6, 2025 | Mar 6, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| 4 | Insider transaction | Jan 31, 2025 | Jan 30, 2025 |
| 4 | Insider transaction | Jan 31, 2025 | Jan 30, 2025 |
| 4 | Insider transaction | Jan 31, 2025 | Jan 30, 2025 |
| 4 | Insider transaction | Jan 31, 2025 | Jan 30, 2025 |
| 4 | Insider transaction | Jan 31, 2025 | Jan 30, 2025 |
| 4 | Insider transaction | Dec 16, 2024 | Dec 13, 2024 |
| 4 | Insider transaction | Dec 16, 2024 | Dec 13, 2024 |
| 4 | Insider transaction | Dec 16, 2024 | Dec 13, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 8, 2024 | — |
| 10-Q | Quarterly report | Nov 5, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2024 | Nov 5, 2024 |
| SC 13G | Ownership over 5% (passive) | Oct 24, 2024 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure, Other events
|
Oct 7, 2024 | Oct 7, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 23, 2024 | Sep 23, 2024 |
| 4 | Insider transaction | Sep 20, 2024 | Sep 20, 2024 |
| 4 | Insider transaction | Sep 20, 2024 | Sep 20, 2024 |
| 4 | Insider transaction | Sep 20, 2024 | Sep 20, 2024 |
| 4 | Insider transaction | Aug 30, 2024 | Aug 28, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Aug 8, 2024 | — |
| 10-Q | Quarterly report | Aug 6, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2024 | Aug 6, 2024 |
| 144 | Notice of proposed sale | Jul 31, 2024 | — |
| 144 | Notice of proposed sale | Jul 26, 2024 | — |
| 144 | Notice of proposed sale | Jul 16, 2024 | — |
| 144 | Notice of proposed sale | Jul 11, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jul 10, 2024 | — |
| 144 | Notice of proposed sale | Jul 9, 2024 | — |
| 144 | Notice of proposed sale | Jun 28, 2024 | — |
| 144 | Notice of proposed sale | Jun 27, 2024 | — |
| 144 | Notice of proposed sale | Jun 26, 2024 | — |
| 144 | Notice of proposed sale | Jun 24, 2024 | — |
| 144 | Notice of proposed sale | Jun 21, 2024 | — |
| 4 | Insider transaction | Jun 21, 2024 | Jun 21, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 21, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 21, 2024 |
| 144 | Notice of proposed sale | Jun 20, 2024 | — |
| 144 | Notice of proposed sale | Jun 20, 2024 | — |
| 144 | Notice of proposed sale | Jun 18, 2024 | — |
| 144 | Notice of proposed sale | Jun 14, 2024 | — |
| 144 | Notice of proposed sale | Jun 13, 2024 | — |
| 144 | Notice of proposed sale | Jun 12, 2024 | — |
| 4 | Insider transaction | Jun 6, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Jun 6, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Jun 6, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Jun 6, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Jun 6, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Jun 6, 2024 | Jun 6, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 6, 2024 | Jun 6, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | May 13, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | May 9, 2024 | — |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| ARS | Annual report to shareholders | Apr 24, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 24, 2024 | — |
| DEF 14A | Proxy statement | Apr 24, 2024 | Jun 6, 2024 |
| 4 | Insider transaction | Apr 12, 2024 | Apr 10, 2024 |
| 4 | Insider transaction | Apr 12, 2024 | Apr 10, 2024 |
| 3 | Initial insider ownership | Apr 12, 2024 | Apr 10, 2024 |
| 3 | Initial insider ownership | Apr 12, 2024 | Apr 10, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 12, 2024 | Jun 6, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 11, 2024 | Apr 10, 2024 |
| 4 | Insider transaction | Apr 3, 2024 | Mar 15, 2024 |
| 4 | Insider transaction | Apr 3, 2024 | Mar 15, 2024 |
| S-8 | Employee stock plan registration | Mar 12, 2024 | — |
| 10-K | Annual report | Mar 12, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 12, 2024 | Mar 12, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Mar 11, 2024 | — |
| 4 | Insider transaction | Feb 15, 2024 | Feb 14, 2024 |
| 4 | Insider transaction | Feb 15, 2024 | Feb 14, 2024 |
| 4 | Insider transaction | Feb 15, 2024 | Feb 14, 2024 |
| 4 | Insider transaction | Feb 15, 2024 | Feb 14, 2024 |
| 4 | Insider transaction | Feb 15, 2024 | Feb 14, 2024 |
| 4 | Insider transaction | Feb 15, 2024 | Feb 14, 2024 |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Jan 18, 2024 | Jan 17, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 4, 2024 | Jan 4, 2024 |
| 4 | Insider transaction | Dec 15, 2023 | Dec 15, 2023 |
| 4 | Insider transaction | Dec 15, 2023 | Dec 15, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 13, 2023 | Dec 13, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | Nov 9, 2023 | — |
| 10-Q | Quarterly report | Nov 6, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2023 | Nov 6, 2023 |
| 4 | Insider transaction | Oct 19, 2023 | Oct 17, 2023 |
| 4 | Insider transaction | Sep 18, 2023 | Sep 15, 2023 |
| 4 | Insider transaction | Sep 18, 2023 | Sep 15, 2023 |
| 4 | Insider transaction | Sep 18, 2023 | Sep 15, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 18, 2023 | Sep 15, 2023 |
| 10-Q | Quarterly report | Aug 11, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2023 | Aug 11, 2023 |
| 4 | Insider transaction | Jul 7, 2023 | Jul 5, 2023 |
| 4 | Insider transaction | Jul 6, 2023 | Jul 5, 2023 |
| 4 | Insider transaction | Jul 3, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Material agreement
|
Jun 30, 2023 | Jun 29, 2023 |
| 424B5 | Prospectus supplement | Jun 30, 2023 | — |
| 4 | Insider transaction | Jun 29, 2023 | Jun 27, 2023 |
| 424B5 | Prospectus supplement | Jun 29, 2023 | — |
| 4 | Insider transaction | Jun 28, 2023 | Jun 27, 2023 |
| 144 | Notice of proposed sale | Jun 27, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 27, 2023 | Jun 27, 2023 |
| 4 | Insider transaction | Jun 16, 2023 | Jun 16, 2023 |
| 4 | Insider transaction | Jun 16, 2023 | Jun 16, 2023 |
| 4 | Insider transaction | Jun 16, 2023 | Jun 16, 2023 |
| 4 | Insider transaction | May 17, 2023 | May 16, 2023 |
| 4 | Insider transaction | May 17, 2023 | May 16, 2023 |
| 4 | Insider transaction | May 17, 2023 | May 16, 2023 |
| 4 | Insider transaction | May 17, 2023 | May 16, 2023 |
| 4 | Insider transaction | May 17, 2023 | May 16, 2023 |
| 4 | Insider transaction | May 17, 2023 | May 16, 2023 |
| 4 | Insider transaction | May 17, 2023 | May 16, 2023 |
| 4 | Insider transaction | May 17, 2023 | May 16, 2023 |
| 8-K |
Current report
Shareholder vote results
|
May 16, 2023 | May 16, 2023 |
| 10-Q | Quarterly report | May 9, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 9, 2023 | May 9, 2023 |
| ARS | Annual report to shareholders | Apr 4, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 4, 2023 | — |
| DEF 14A | Proxy statement | Apr 4, 2023 | May 16, 2023 |
| 4 | Insider transaction | Mar 20, 2023 | Mar 16, 2023 |
| 4 | Insider transaction | Mar 20, 2023 | Mar 16, 2023 |
| 4 | Insider transaction | Mar 20, 2023 | Mar 16, 2023 |
| S-8 | Employee stock plan registration | Mar 9, 2023 | — |
| 10-K | Annual report | Mar 9, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 9, 2023 | Mar 9, 2023 |
| 4 | Insider transaction | Feb 15, 2023 | Feb 13, 2023 |
| 4 | Insider transaction | Feb 15, 2023 | Feb 13, 2023 |
| 4 | Insider transaction | Feb 15, 2023 | Feb 13, 2023 |
| 4 | Insider transaction | Feb 15, 2023 | Feb 13, 2023 |
| 4 | Insider transaction | Feb 15, 2023 | Feb 13, 2023 |
| 4 | Insider transaction | Feb 15, 2023 | Feb 13, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- BDTX (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Cambridge, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1701541
- Former names
- Aset Therapeutics, Inc. (until Jan 4, 2018)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.